Cargando…

Creation of a transgenic mouse model to study the SARS-CoV-2 effect on the pathogenesis of atherosclerosis

Detalles Bibliográficos
Autores principales:	Kubekina, M., Ilchuk, L., Bruter, A., Deykin, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415862/ http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.236

Ejemplares similares

Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis
por: Bruter, Alexandra V., et al.
Publicado: (2021)

Genetically Engineered Mice Unveil In Vivo Roles of the Mediator Complex
por: Ilchuk, Leonid A., et al.
Publicado: (2023)

An update on the tools for creating transgenic animal models of human diseases – focus on atherosclerosis
por: Volobueva, A.S., et al.
Publicado: (2019)

An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo
por: Liu, Kuo, et al.
Publicado: (2023)

The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2
por: Dolskiy, Alexander A., et al.
Publicado: (2022)

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
por: Sun, Shi-Hui, et al.
Publicado: (2020)

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
por: Jiang, Ren-Di, et al.
Publicado: (2020)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model
por: Qiao, Jingxin, et al.
Publicado: (2021)

Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
por: Saravanan, Udhaya Bharathy, et al.
Publicado: (2022)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

Preparing for the SARS-CoV-2 pandemic: creation and implementation of new recommendations
por: Conrad, David, et al.
Publicado: (2020)

Cell and animal models of SARS-CoV-2 pathogenesis and immunity
por: Leist, Sarah R., et al.
Publicado: (2020)

Early Isolates of SARS-CoV-2 Result in Different Pathogenesis in the Transduced Mouse Model of COVID-19
por: Smither, Sophie J., et al.
Publicado: (2022)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
por: Harrison, Andrew G., et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

Epidemiology, transmission and pathogenesis of SARS-CoV-2
por: Sindhuja, Tulasi, et al.
Publicado: (2022)

Animal models of human atherosclerosis: current progress
por: Poznyak, A.V., et al.
Publicado: (2020)

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
por: Dedoni, Simona, et al.
Publicado: (2022)

Evaluation of Interferon Inducers, Ribavirin and Mouse Hyperimmune Serum in a Pathogenesis/Lethal Mouse Model Using a Mouse-adapted SARS-CoV
por: Barnard, Dale, et al.
Publicado: (2008)

Increased LAMP1 Expression Enhances SARS-CoV-1 and SARS-CoV-2 Production in Vero-Derived Transgenic Cell Lines
por: Dolskiy, A. A., et al.
Publicado: (2022)

SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment
por: Khalaf, Khalil, et al.
Publicado: (2020)

Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
por: Shah, Taif, et al.
Publicado: (2022)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Substances of abuse and their effect on SAR-CoV-2 pathogenesis
por: Antwi, Ivy, et al.
Publicado: (2023)

Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines
por: Battulin, N.R., et al.
Publicado: (2022)

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2022)

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2022)

COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2
por: Hisham, Yasmin, et al.
Publicado: (2023)

Potent NKT cell ligands overcome SARS-CoV-2 immune evasion to mitigate viral pathogenesis in mouse models
por: Lu, Hongjia, et al.
Publicado: (2023)

Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2020)

SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium
por: Sims, Amy C., et al.
Publicado: (2008)

In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease
por: Heinen, Natalie, et al.
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Muruato, Antonio, et al.
Publicado: (2021)

Mouse Adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Muruato, Antonio, et al.
Publicado: (2021)

Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection
por: Liu, Ya, et al.
Publicado: (2021)

SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis
por: Płazak, Wojciech, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fqaqom1cv6ghp38csgcthtkc8g